BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24276779)

  • 1. Impact of wait times on survival for women with uterine cancer.
    Elit LM; O'Leary EM; Pond GR; Seow HY
    J Clin Oncol; 2014 Jan; 32(1):27-33. PubMed ID: 24276779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The wait time creep: changes in the surgical wait time for women with uterine cancer in Ontario, Canada, during 2000-2009.
    O'Leary E; Elit L; Pond G; Seow H
    Gynecol Oncol; 2013 Oct; 131(1):151-7. PubMed ID: 23838037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival.
    Helewa RM; Turner D; Park J; Wirtzfeld D; Czaykowski P; Hochman D; Singh H; Shu E; McKay A
    J Surg Oncol; 2013 Nov; 108(6):378-84. PubMed ID: 24037666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
    Farley JH; Nycum LR; Birrer MJ; Park RC; Taylor RR
    Gynecol Oncol; 2000 Oct; 79(1):86-9. PubMed ID: 11006037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical wait time: A new health indicator in women with endometrial cancer.
    Strohl AE; Feinglass JM; Shahabi S; Simon MA
    Gynecol Oncol; 2016 Jun; 141(3):511-515. PubMed ID: 27103178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
    Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative wait times in high-grade non-endometrioid endometrial cancer: Do surgical delays impact patient survival?
    Nica A; Sutradhar R; Kupets R; Covens A; Vicus D; Li Q; Ferguson SE; Gien LT
    Gynecol Oncol; 2022 Feb; 164(2):333-340. PubMed ID: 34895897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment delay in endometrial cancer.
    Menczer J
    J Clin Oncol; 2014 Jul; 32(19):2113-4. PubMed ID: 24841976
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer wait times increase overall mortality in patients with bladder cancer.
    Kulkarni GS; Urbach DR; Austin PC; Fleshner NE; Laupacis A
    J Urol; 2009 Oct; 182(4):1318-24. PubMed ID: 19683272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment delay in endometrial cancer. Reply to J. Menczer.
    Elit LM; Pond G; Seow HY
    J Clin Oncol; 2014 Jul; 32(19):2114. PubMed ID: 24841980
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
    Chan JK; Kapp DS; Cheung MK; Shin JY; Stieglitz D; Husain A; Teng NN; Berek JS; Osann K; Guo H
    Am J Obstet Gynecol; 2008 Feb; 198(2):216.e1-5. PubMed ID: 18226629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lymphadenectomy in uterine endometrioid carcinoma.
    Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
    Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for uterine cancer in reproductive-aged women.
    Lee NK; Cheung MK; Shin JY; Husain A; Teng NN; Berek JS; Kapp DS; Osann K; Chan JK
    Obstet Gynecol; 2007 Mar; 109(3):655-62. PubMed ID: 17329517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
    Rauh-Hain JA; Davis M; Clemmer J; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Nov; 131(2):404-9. PubMed ID: 24004647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of lymphadenectomy in uterine serous cancer.
    Mahdi H; Kumar S; Al-Wahab Z; Ali-Fehmi R; Munkarah AR
    BJOG; 2013 Mar; 120(4):384-91. PubMed ID: 22827595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.
    Chan JK; Kapp DS; Cheung MK; Osann K; Shin JY; Cohn D; Seid PL
    Br J Cancer; 2007 Sep; 97(5):605-11. PubMed ID: 17667929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.